CAS 80214-83-1
:Roxithromycin
Description:
Roxithromycin is a semi-synthetic macrolide antibiotic that is primarily used to treat various bacterial infections. It is derived from erythromycin and exhibits a broad spectrum of activity against both Gram-positive and some Gram-negative bacteria. The chemical structure of Roxithromycin includes a lactone ring, which is characteristic of macrolides, and it features a 14-membered ring that contributes to its antibacterial properties. Roxithromycin works by inhibiting bacterial protein synthesis, effectively blocking the growth and reproduction of bacteria. It is typically administered orally and is known for its favorable pharmacokinetic profile, including good tissue penetration and a relatively long half-life, allowing for once-daily dosing in many cases. Common indications for Roxithromycin include respiratory tract infections, skin infections, and certain sexually transmitted infections. While generally well-tolerated, potential side effects may include gastrointestinal disturbances and allergic reactions. As with all antibiotics, it is essential to use Roxithromycin judiciously to minimize the risk of developing antibiotic resistance.
Formula:C41H76N2O15
InChI:InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1
InChI key:InChIKey=RXZBMPWDPOLZGW-XMRMVWPWSA-N
SMILES:O([C@H]1[C@H](C)[C@@H](O[C@H]2[C@H](O)[C@@H](N(C)C)C[C@@H](C)O2)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)/[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3
Synonyms:- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2-methoxyethoxy)methoxy]imino}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (non-preferred name)
- 5-(3,4,6-Trideoxy-3-Dimethylamino-Beta-D-Xylo-Hexopyranosyloxy)-3-(2,6-Dideoxy-3-C-Methyl-3-O-Methyl-Alpha-L-Ribo-Hexopyranosyloxy)-6,11,12-Trihydroxy-9-(2-Methoxyethoxy)Methoxyimino-2,4,6,8,10,12-Hexamethylpentadecan-13-Olide
- Assoral
- Biaxsig
- Brilid
- Claramid
- Erythromycin, 9-[O-[(2-methoxyethoxy)methyl]oxime], (9E)-
- Forilin
- Overal
- Oxacyclotetradecane, erythromycin deriv.
- Rossitrol
- Rotramin
- Roxacin
- Roxar
- Roxeptin
- Roxibest-A
- Roxid
- Roxid-M
- Roximycin
- Roxithromycin A
- Roxithromycine
- Roxl 150
- Roxxibid
- Roxythromycin
- Ru 28965
- Ru 965
- Rulid
- Rulide
- Surlid
- Xthrocin
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Roxithromycin
CAS:Formula:C41H76N2O15Purity:>95.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:837.06Roxithromycin, 97%
CAS:Roxithromycin, 97%; Semi-synthetic macrolide antibiotic.Formula:C41H76N2O15Purity:97%Molecular weight:837.04ROXITHROMYCIN FOR SYSTEM SUITABILITY CRS
CAS:ROXITHROMYCIN FOR SYSTEM SUITABILITY CRSFormula:C41H76N2O15Molecular weight:837.0465ROXITHROMYCIN CRS
CAS:ROXITHROMYCIN CRSFormula:C41H76N2O15Color and Shape:Added ModifiedMolecular weight:837.0465Erythromycin, 9-[O-[(2-methoxyethoxy)methyl]oxime], (9E)- (9CI)
CAS:Formula:C41H76N2O15Purity:95%Color and Shape:SolidMolecular weight:837.0465Roxithromycin
CAS:Roxithromycin (RU-28965) is a semi-synthetic derivative of the macrolide antibiotic erythromycin with antibacterial and anti-malarial activities.Formula:C41H76N2O15Purity:99.29% - 99.98%Color and Shape:White SolidMolecular weight:837.05Roxithromycin, EP grade
CAS:Formula:C41H76N2O15Purity:≤ 1.0%Color and Shape:White or almost white crystalline powderMolecular weight:837.05Roxithromycin
CAS:Formula:C41H76N2O15Purity:95.0 - 102.0 % (anhydrous basis)Color and Shape:White to almost white crystalline powderMolecular weight:837.05LC PestiMix 5 10 µg/mL in Acetonitrile
CAS:Controlled Product- 100986-85-4
- 101-27-9
- 1014-69-3
- 104030-54-8
- 106700-29-2
- 112143-82-5
- 1134-23-2
- 115-26-4
- 117718-60-2
- 127-79-7
- 131341-86-1
- 14086-35-2
- 1491-41-4
- 15310-01-7
- 153197-14-9
- 1593-77-7
- 1596-84-5
- 183675-82-3
- 18854-01-8
- 1918-11-2
- 1929-77-7
- 210880-92-5
- 219714-96-2
- 22936-86-3
- 2307-68-8
- 23564-06-9
- 25366-23-8
- 2588-03-6
- 2588-04-7
- 2588-05-8
- 2588-06-9
- 26087-47-8
- 2686-99-9
- 299-86-5
- 30043-49-3
- 31120-85-1
- 314-40-9
- 3244-90-4
- 3813-05-6
- 3983-45-7
- 470-90-6
- 4726-14-1
- 51218-45-2
- 535-89-7
- 53780-34-0
- 59756-60-4
- 61676-87-7
- 62850-32-2
- 64249-01-0
- 644-64-4
- 6552-12-1
- 6552-13-2
- 67018-59-1
- 672-99-1
- 673-04-1
- 70217-36-6
- 70630-17-0
- 741-58-2
- 759-94-4
- 7700-17-6
- 78-30-8
- 79540-50-4
- 80214-83-1
- 81335-37-7
- 83657-22-1
- 85785-20-2
- 86763-47-5
- 88283-41-4
- 89784-60-1
- 947-02-4
- 95-06-7
- 96491-05-3
- 99485-76-4
- 99675-03-3
Color and Shape:MixtureRoxithromycin 100 µg/mL in Acetonitrile
CAS:Formula:C41H76N2O15Color and Shape:Single SolutionMolecular weight:837.05Roxithromycin
CAS:(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(((2-methoxyethoxy)methoxy)imino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-oneFormula:C41H76N2O15Purity:95%Molecular weight:837.05Roxithromycin
CAS:Applications Semisynthetic Erythromycin derivative. Antibacterial.This compound is a contaminant of emerging concern (CECs).
References Jones, R.N., et al.: Antimicrob. Agents Chemother., 24, 209 (1983), Barry, A.L., et al.: Eur. J. Clin. Microbiol., 5, 536 (1986), Grassi, C., et al.: Chemioterapia, 6, 41 (1987),Formula:C41H76N2O15Color and Shape:NeatMolecular weight:837.05













